# Clearum High Flux Hemodialyzer Used in Hemodialysis for Subjects With End-Stage Renal Disease

> **NCT04395131** · NA · COMPLETED · sponsor: **Mozarc Medical US LLC** · enrollment: 20 (actual)

## Conditions studied

- End-stage Renal Disease

## Interventions

- **DEVICE:** Clearum HF Hemodialyzer

## Key facts

- **NCT ID:** NCT04395131
- **Lead sponsor:** Mozarc Medical US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-03
- **Primary completion:** 2020-08-14
- **Final completion:** 2020-08-14
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04395131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04395131, "Clearum High Flux Hemodialyzer Used in Hemodialysis for Subjects With End-Stage Renal Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04395131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*